AU2002221017A1 - Methods and kits for diagnosis of schizophrenia - Google Patents

Methods and kits for diagnosis of schizophrenia

Info

Publication number
AU2002221017A1
AU2002221017A1 AU2002221017A AU2101702A AU2002221017A1 AU 2002221017 A1 AU2002221017 A1 AU 2002221017A1 AU 2002221017 A AU2002221017 A AU 2002221017A AU 2101702 A AU2101702 A AU 2101702A AU 2002221017 A1 AU2002221017 A1 AU 2002221017A1
Authority
AU
Australia
Prior art keywords
schizophrenia
kits
diagnosis
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221017A
Inventor
Dorit Ben-Shachar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RAMBAM MEDICAL CENTER FUNDS FOR MEDICAL RESEARCH DEVELOPMENT OF INFRASTRUCTURE AND HEALTH SERVICES
Original Assignee
RAMBAM MEDICAL CT FUNDS FOR ME
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RAMBAM MEDICAL CT FUNDS FOR ME filed Critical RAMBAM MEDICAL CT FUNDS FOR ME
Publication of AU2002221017A1 publication Critical patent/AU2002221017A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/302—Schizophrenia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002221017A 2000-11-30 2001-11-29 Methods and kits for diagnosis of schizophrenia Abandoned AU2002221017A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25392700P 2000-11-30 2000-11-30
US60/253,927 2000-11-30
PCT/IL2001/001106 WO2002043559A2 (en) 2000-11-30 2001-11-29 Methods and kits for diagnosis of schizophrenia

Publications (1)

Publication Number Publication Date
AU2002221017A1 true AU2002221017A1 (en) 2002-06-11

Family

ID=22962247

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221017A Abandoned AU2002221017A1 (en) 2000-11-30 2001-11-29 Methods and kits for diagnosis of schizophrenia

Country Status (3)

Country Link
US (1) US7442496B2 (en)
AU (1) AU2002221017A1 (en)
WO (1) WO2002043559A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8420308B2 (en) * 2000-11-30 2013-04-16 Technion R&D Foundation Ltd. Methods and kits for diagnosis of schizophrenia
WO2010101950A1 (en) * 2009-03-02 2010-09-10 Catholic Healthcare West Diagnostic devices and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888498A (en) * 1995-03-03 1999-03-30 Mitokor Cellular and animal models for diseases associated with mitochondrial defects
WO1999055321A1 (en) * 1998-04-24 1999-11-04 Mitokor Compounds and methods for treating mitochondria-associated diseases
US6218117B1 (en) * 1998-06-15 2001-04-17 Mitokor Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios

Also Published As

Publication number Publication date
US7442496B2 (en) 2008-10-28
WO2002043559A2 (en) 2002-06-06
US20040048236A1 (en) 2004-03-11
WO2002043559A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
IL153824A0 (en) Method and kit for diagnosis of diseases
AU2001288249A1 (en) Biosensors and methods for their use
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001275047A1 (en) Method of graphically indicating patient information
AU2001275870A1 (en) Methods and kits for the detection of arginine compounds
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU2001290309A1 (en) Method of diagnosing nephropathy
AU2001238696A1 (en) Method of reducing defects
AU2002221906A1 (en) Method for diagnosing allergic diseases
AU2001275007A1 (en) Methods of testing materials
AU2003292231A1 (en) Methods for diagnosing and treating schizophrenia
AU2001247196A1 (en) Methods and compositions for detection of disease
AU1085401A (en) Genotyping reagents, kits and methods of use thereof
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2002214189A1 (en) Methods of identifying inhibitory compounds and uses thereof
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2002221017A1 (en) Methods and kits for diagnosis of schizophrenia
AU2001287007A1 (en) Reagents and methods for the diagnosis of cmv dissemination
AU7446501A (en) Diagnostic kit for invitro detection of hepatitis c
AU2001257164A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001259127A1 (en) Methods and composition for the diagnosis of schizophrenia
AU2001255606A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001255597A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001257180A1 (en) Methods and compositions for the diagnosis of schizophrenia